LinXis will attend EANM in Hamburg from October 19-23, where we will also present the preclinical results-to-date on our lead Fibrobody® in a Top Rated Oral Presentation.
Read all about the preclinical validation of our lead Fibrobody® in the European Journal of Nuclear Medicine and Molecular Imaging.
We are proud to welcome Guus van Dongen as our full-time CSO.